Assessing the impact of simplified HCV care on linkage to care amongst high-risk patients at primary healthcare clinics in Malaysia: a prospective observational study. Issue 12 (24th December 2021)

• Record Type: Journal Article
• Authors: Markby, Jessica; Shilton, Sonjelle; Sem, Xiaohui; Chan, Huan Keat; Md Said, Rosaida; Siva, Sasikala; Zainuddin, Zalwani; Abu Bakar, Norasiah; Omar, Haniza; Ruiz, Ryan Jose III; Gaeddert, Mary; Tyshkovskiy, Alexander; Adee, Madeline; Chhatwal, Jagpreet; Kumar, Suresh; Piedagnel, Jean-Michel; Mohd Zain, Rozainanee; Menétrey, Caroline; Yuswan, Fazidah; Hairizan Nasir, Nazrila; Andrieux-Meyer, Isabelle; Ismail, Fatanah; Zakaria, Rozita; Hasim, Ruziaton; Murad, Shahnaz; Easterbrook, Philippa; Hassan, Muhammad Radzi Abu
• Is Part Of: BMJ open. Volume 11:Issue 12(2021)
• Publication Date: 2021-12-24
• Subjects: public health -- hepatology -- primary care; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2021-055142
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Introduction: To achieve the elimination of hepatitis C virus (HCV), substantial scale-up in access to testing and treatment is needed. This will require innovation and simplification of the care pathway, through decentralisation of testing and treatment to primary care settings and task-shifting to non-specialists. The objective of this study was to evaluate the feasibility and effectiveness of decentralisation of HCV testing and treatment using rapid diagnostic tests (RDTs) in primary healthcare clinics (PHCs) among high-risk populations, with referral of seropositive patients for confirmatory viral load testing and treatment. Methods: This observational study was conducted between December 2018 and October 2019 at 25 PHCs in three regions in Malaysia. Each PHC was linked to one or more hospitals, for referral of seropositive participants for confirmatory testing and pretreatment evaluation. Treatment was provided in PHCs for non-cirrhotic patients and at hospitals for cirrhotic patients. Results: During the study period, a total of 15 366 adults were screened at the 25 PHCs, using RDTs for HCV antibodies. Of the 2020 (13.2%) HCV antibody-positive participants, 1481/2020 (73.3%) had a confirmatory viral load test, 1241/1481 (83.8%) were HCV RNA-positive, 991/1241 (79.9%) completed pretreatment assessment, 632/991 (63.8%) initiated treatment, 518/632 (82.0%) completed treatment, 352/518 (68.0%) were eligible for a sustained virological response (SVR) cure assessment, 209/352 (59.4%) had an SVR cure assessment, and SVR was achieved in 202/209 (96.7%) patients. A significantly higher proportion of patients referred to PHCs initiated treatment compared with those who had treatment initiated at hospitals (71.0% vs 48.8%, p<0.001). Conclusions: This study demonstrated the effectiveness and feasibility of a simplified decentralised HCV testing and treatment model in primary healthcare settings, targeting high-risk groups in Malaysia. There were good outcomes across most steps of the cascade of care when treatment was provided at PHCs compared with hospitals.